source
- Capricor boosts manufacturing capacity as FDA decision on DMD cell therapy loomsCapricor Therapeutics, a biotech developing a cell therapy for Duchenne muscular dystrophy, is preparing for an FDA decision expected by late November. The company’s third-quarter operating expens…
- Flagship Pioneering combines Valo Health and Montai Therapeutics into a single companyFlagship Pioneering announced that two of its portfolio companies, Valo Health and Montai Therapeutics, are merging to form a new entity. The combined firm will consolidate resources and expertise…